Medical/Pharmaceuticals

XtalPi AI Enables Seven-Month PCC Nomination for Viva-Thera's MPER-Targeting HIV-1 Program

* Viva-Thera makes its public debut with four modalities pursuing HIV prevention, treatment and cure, supported by XtalPi's platform capabilities. * Viva-Thera combines its first atomic-resolution MPER-TMD-CT structure with XtalPi's AI and automation platform to advance a small-molecule PCC. ...

2026-09-23 01:36 1528

Tsingke Enables High-Throughput Validation of AI-Designed Proteins and Antibodies

BEIJING, Sept. 22, 2026 /PRNewswire/ -- Tsingke today announced an integrated high-throughput validation workflow designed to help researchers experimentally evaluate large libraries of AI-designed proteins and antibodies. Combining gene synthesis, parallel expression, high-throughput screening, ...

2026-09-22 22:22 1152

Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration

* New flagship facility provides hands-on access to Bio-Techne technologies, workflows and scientific expertise * Regional hub will support researchers and organizations across the DACH and broader EMEA regions * Center strengthens collaboration, training and innovation within Europe's life...

2026-09-22 21:00 2789

AIMD Expands A-LRYNGO, the World's First AI-Guided Video Laryngoscope, to Global Markets

Dual Korean Government Recognition Advances AI-Guided Intubation Toward a New Standard in Airway Management SEOUL, South Korea, Sept. 22, 2026 /PRNewswire/ -- AIMD Inc., a Korean medical technology company specializing in AI-powered emergency care, announced the global expansion ofA-LRYNGO™, the...

2026-09-22 21:00 1610

From Next-Gen AI to Surgical Robots: IEEE Celebrates the Technical Innovators Shaping the Future

World's leading technology and engineering community unveils 2027 Technical Field Awards, recognizing achievements in medical robotics, wireless networks, digital privacy, power electronics, computing technology, and more PISCATAWAY, N.J., Sept. 22, 2026 /PRNewswire/ -- Celebrating innovations r...

2026-09-22 21:00 1369

Kazia Therapeutics Announces Sovargen Co. Doses First Patient in Phase 1b/2a Trial of Paxalisib for Rare Seizure Disorders

Clinical Milestone Expands Development of Paxalisib Beyond Oncology and Triggers $2 Million Payment to Kazia SYDNEY, Sept. 22, 2026 /PRNewswire/ -- Kazia Therapeutics Limited

2026-09-22 19:30 2600

Multiple Sacituzumab Tirumotecan (sac-TMT) Studies Selected as LBAs at ESMO 2026, OptiTROP-Lung04 and OptiTROP-Lung06 to be Presented in the Lung Cancer Session

CHENGDU, China, Sept. 22, 2026 /PRNewswire/ -- The 2026 European Society for Medical Oncology (ESMO) Congress will be held in Madrid, Spain, from October 23 to 27. Multiple Phase III clinical studies of the TROP2 ADC sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) (佳泰莱®) developed...

2026-09-22 15:48 2461

NUH ENDOCRINOLOGY TEAM SHOWCASES END-TO-END CARE MODEL THAT PROTECTS HOSPITALISED PATIENTS WITH DIABETES MELLITUS (DM) ACROSS THEIR CARE JOURNEY

NUH's Inpatient DM management team highlights how safe prescribing is strengthened through proactive monitoring, rapid intervention and coordinated care transitions. SINGAPORE, Sept. 21, 2026 /PRNewswire/ -- Newer diabetes treatments are transforming care, helping patients not only manage their ...

2026-09-22 15:46 1386

BoomRay Enters Exclusive Global License Agreement with Novartis for a Novel Radioligand Therapy Asset

SUZHOU, China, Sept. 22, 2026 /PRNewswire/ -- Boomray Pharmaceuticals Co., Ltd. ("BoomRay"), a clinical-stage biotechnology company pioneering innovative radioligand therapies (RLTs) for precision oncology diagnostics and therapeutics, today announced that it has entered into an exclusive global ...

2026-09-22 12:00 2461

Ivonescimab First-Line Biliary Tract Cancer Phase III Overall Survival Data Selected as ESMO Late-Breaking Abstract; Nearly 30 Akeso Studies to Be Presented at ESMO 2026

HONG KONG, Sept. 21, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company")announced that nearly 30 clinical studies of its globally first-in-class bispecific antibodies will be presented at the 2026 European Society for Medical Oncology (ESMO) Congress, taking place October 23–27 ...

2026-09-22 07:46 3535

Red Sea Global and Dr. Sulaiman Al Habib Medical Group Inaugurate The Red Sea Hospital

- The new hospital advances RSG's vision for an integrated healthcare ecosystem across its destinations RIYADH, Saudi Arabia, Sept. 21, 2026 /PRNewswire/ -- Under the patronage of H.E. Fahad Abdulrahman AlJalajel, Minister of Health of the Kingdom of Saudi Arabia, Red Sea Global (RSG), the devel...

2026-09-21 21:34 2059

The Next Chapter of B7-H3: From Systemic Disease to the Brain

Early Data for T-MAXIMUM's B7-H3 Allogeneic CAR-T in Brain Metastases Presented at WCLC 2026 BEIJING, Sept. 21, 2026 /PRNewswire/ -- As B7-H3 ADCs reshape the second-line treatment landscape for small cell lung cancer at WCLC, a more specific question comes into focus: systemic disease now has n...

2026-09-21 19:50 1753

WuXi XDC Celebrates GMP Release of Singapore Site, Ushering in a New Era of Global Expansion

SINGAPORE, Sept. 21, 2026 /PRNewswire/ --WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, today held a grand GMP release ceremony for its Singapore manufacturing sit...

2026-09-21 17:50 3233

Neuralli™ MP Goes Global: US Probiotic Medical Food Meets Singapore HSA Notification

Milestone Builds on Hong Kong's Healthcare Professionals Choice Probiotic Award and Full US HSA/FSA Payment Eligibility SINGAPORE, Sept. 21, 2026 /PRNewswire/ -- Bened Life, the leader in psychobiotics, has completed voluntary notification for its flagship product, Neuralli™ MP, withSingapore's ...

2026-09-21 15:10 1805

6 countries across Terumo Asia Pacific officially recognized as Best Workplaces™ Certified by Great Place To Work®

SINGAPORE, Sept. 21, 2026 /PRNewswire/ -- Terumo is proud to announce that 6 countries across Terumo Asia Pacific have officially been recognized as Best Workplaces™ Certified by Great Place To Work®.

2026-09-21 12:00 928

MALAYSIA HEALTHCARE DEEPENS BANGLADESH PRESENCE AS MEDICAL TOURISM DEMAND GROWS

CHATTOGRAM, Bangladesh, Sept. 21, 2026 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC) deepened its engagement in Bangladesh through Malaysia Healthcare Week in Bangladesh, held from 16 to 21 September, bringing Malaysian hospitals and healthcare stakeholders together across Dhaka and C...

2026-09-21 10:41 2473

Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse

* Transformational merger reinforces Telix's long-term growth strategy as a vertically integrated radiopharmaceutical company with enhanced capabilities across development, isotope production and global manufacturing, underpinned by commercial excellence and the industry's most extensive therap...

2026-09-21 09:59 2536

Antengene Announces First Patient Dosed in Pivotal Phase III CLINCH-3 Study of ATG-022

SHANGHAI and HONG KONG, Sept. 21, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune di...

2026-09-21 08:30 2159

Specialised Therapeutics Expands Partnership with Incyte to Include Ruxolitinib Cream (Opzelura®) in Australia

SINGAPORE, Sept. 20, 2026 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics (ST)today announced an expansion of its existing partnership with Incyte Biosciences International, an affiliate of Incyte (NASDAQ: INCY), to commercialise, distribute, and register ruxolitini...

2026-09-21 04:00 2903

JACC: Clinical Electrophysiology Publishes 12-Month Outcomes from Field Medical's First-in-Human Field PULSE Trial: 94.2% Per-Vein PVI Durability with Optimized Waveform

Late-breaking HRX data advance Field Medical's "instantaneous ablation" workflow and expand the clinical evidence for high-voltage focal PFA with the FieldForce™ PFA System ATLANTA and CARLSBAD, Calif., Sept. 20, 2026 /PRNewswire/ -- Field Medical, Inc.

2026-09-20 22:53 2866
1 ... 20212223242526 ... 642